Fertility outcome of hyperprolactinemic infertile women undergoing induction of ovulation for intrauterine insemination (IUI): A comparison between Bromocriptine and Cabergoline.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Bromocriptine (Primary) ; Cabergoline (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 25 Aug 2011 Official title amended, actual initiation date (Mar 2005) added as reported by ClinicalTrials.gov.
- 25 Aug 2011 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT138806142420N1).
- 05 Nov 2010 New trial record.